Obesity hypoventilation syndrome: Therapeutic implications for treatment

Expert Review of Respiratory Medicine

Volumn 4, Issue 1, 2010, Pages 57-70

  Piper, Amanda ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Continuous positive airway pressure; Hypercapnia; Morbid obesity; Noninvasive ventilation; Obesity hypoventilation syndrome; Obstructive sleep apnea; Respiratory failure; Ventilatory control

Indexed keywords

ACETAZOLAMIDE; LEPTIN; MEDROXYPROGESTERONE; PLACEBO;

ARTIFICIAL VENTILATION; BREATHING MUSCLE; CIRCADIAN RHYTHM; DRUG EFFICACY; DRUG SAFETY; HORMONE BLOOD LEVEL; HUMAN; HYPERCAPNIA; LUNG ALVEOLUS HYPOVENTILATION; LUNG CAPACITY; LUNG FUNCTION; LUNG MECHANICS; MORBID OBESITY; NON INVASIVE PROCEDURE; OBESITY HYPOVENTILATION SYNDROME; OXYGEN THERAPY; PATHOGENESIS; POSITIVE END EXPIRATORY PRESSURE; RESPIRATORY DRIVE; RESPIRATORY FUNCTION; REVIEW; SLEEP APNEA SYNDROME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; WEIGHT REDUCTION;

EID: 77951625099     PISSN: 17476348     EISSN: 17476356     Source Type: Journal    
DOI: 10.1586/ers.09.64     Document Type: Review

References (105)

1. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 295, 1549-1555 (2006).
2. Rennie KL, Jebb SA. Prevalence of obesity in Great Britain. Obesity Rev. 6, 11-12 (2005).
3. Sturm R. Increases in morbid obesity in the USA: 2000-2005. Public Health 121, 492-496 (2007).
4. Andreyeva T, Sturm R, Ringel JS. Moderate and severe obesity have large differences in health care costs. Obesity 12, 1936-1943 (2004).
5. Marshall NS, Wong KK, Liu PY, Cullen SR, Knuiman MW, Grunstein RR. Sleep apnea as an independent risk factor for all-cause mortality: the Busselton Health Study. Sleep 31, 1079-1085 (2008).
6. Young T, Finn L, Peppard PE et al. Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort. Sleep 31, 1071-1078 (2008).
7. Berger KI, Ayappa I, Chatr-Amontri B et al. Obesity hypoventilation syndrome as a spectrum of respiratory disturbances during sleep. Chest 120, 1231-1238 (2001).
8. Kessler R, Chaouat A, Schinkewitch P et al. The obesity-hypoventilation syndrome revisited: a prospective study of 34 consecutive cases. Chest 120, 369-376 (2001).
9. Bandyopadhyay T. Obesity-hypoventilation syndrome: the name game continues. Chest 125, 352 (2004).
10. Rabec CA. Obesity hypoventilation syndrome: what's in a name? Chest 122, 1498 (2002).
11. American Academy of Sleep Medicine. Sleep-related breathing disorders in adults: recommendations for syndrome defnition and measurement techniques in clinical research Sleep 22, 667-689 (1999).
12. Berg G, Delaive K, Manfreda J, Walld R, Kryger MH. The use of health-care resources in obesity-hypoventilation syndrome. Chest 120, 377-383 (2001).
13. Borel J-C, Roux-Lombard P, Tamisier R et al. Endothelial dysfunction and specifc infammation in obesity hypoventilation syndrome. PLoS One 4, e6733 (2009).
14. Nowbar S, Burkart KM, Gonzales R et al. Obesity-associated hypoventilation in hospitalized patients: prevalence, effects, and outcome. Am. J. Med. 116, 1-7 (2004).
15. Budweiser S, Riedl SG, Jorres RA, Heinemann F, Pfeifer M. Mortality and prognostic factors in patients with obesity-hypoventilation syndrome undergoing noninvasive ventilation. J. Intern. Med. 261, 375-383 (2007).
16. Akashiba T, Akahoshi T, Kawahara S et al. Clinical characteristics of obesity-hypoventilation syndrome in Japan: a multi-center study. Intern. Med. 45, 1121-1125 (2006).
17. Laaban J-P, Chailleux E; for the Observatory Group of ANTADIR. Daytime hypercapnia in adult patients with obstructive sleep apnea syndrome in France, before initiating nocturnal nasal continuous positive airway pressure therapy. Chest 127, 710-715 (2005).
18. Mokhlesi B, Tulaimat A, Faibussowitsch I, Wang Y, Evans A. Obesity hypoventilation syndrome: prevalence and predictors in patients with obstructive sleep apnea. Sleep Breath. 11, 117-124 (2007). (Pubitemid 46745864)
19. Resta O, Foschino-Barbaro MP, Bonftto P et al. Prevalence and mechanisms of diurnal hypercapnia in a sample of morbidly obese subjects with obstructive sleep apnea. Respir. Med. 94, 240-246 (2000).
20. Mokhlesi B, Tulaimat A. Recent advances in obesity hypoventilation syndrome. Chest 132, 1322-1336 (2007).
21. Heinemann F, Budweiser S, Dobroschke J, Pfeifer M. Non-invasive positive pressure ventilation improves lung volumes in the obesity hypoventilation syndrome. Respir. Med. 101, 1229-1235 (2007).
22. Mokhlesi B, Tulaimat A, Evans AT et al. Impact of adherence with positive airway pressure therapy on hypercapnia in obstructive sleep apnea. J. Clin. Sleep. Med. 2, 57-62 (2006).
23. Piper AJ, Wang D, Yee BJ, Barnes DJ, Grunstein RR. Randomised trial of CPAPvs bilevel support in the treatment of obesity hypoventilation syndrome without severe nocturnal desaturation. Thorax 63, 395-401 (2008).
24. Santana H, Zoico E, Turcato E et al. Relation between body composition, fat distribution, and lung function in elderly men. Am. J. Clin. Nutr. 73, 827-831 (2001).
25. Naimark A, Cherniack RM. Compliance of the respiratory system and its components in health and obesity. J. Appl. Physiol. 15, 377-382 (1960).
26. Zerah F, Harf A, Perlemuter L, Lorino H, Lorino AM, Atlan G. Effects of obesity on respiratory resistance. Chest 103, 1470-1476 (1993).
27. Pankow W, Hijjeh N, Schuttler F et al. Infuence of noninvasive positive pressure ventilation on inspiratory muscle activity in obese subjects. Eur. Respir. J. 10, 2847-2852 (1997).
28. Lee MY, Lin CC, Shen SY, Chiu CH, Liaw SF. Work of breathing in eucapnic and hypercapnic sleep apnea syndrome. Respiration 77, 146-153 (2009).
29. Ferretti A, Giampiccolo P, Cavalli A, Milic-Emili J, Tantucci C. Expiratory fow limitation and orthopnea in massively obese subjects. Chest 119, 1401-1408 (2001).
30. Pankow W, Podszus T, Gutheil T, Penzel T, Peter J, Von Wichert P. Expiratory fow limitation and intrinsic positive end-expiratory pressure in obesity. J. Appl. Physiol. 85, 1236-1243 (1998).
31. Steier J, Jolley CJ, Seymour JM, Roughton M, Polkey MI, Moxham J. Neural respiratory drive in obesity. Thorax 64, 719-725 (2009).
32. Zavorsky GS, Hoffman SL. Pulmonary gas exchange in the morbidly obese. Obes. Rev. 9, 326-339 (2008).
33. Collet F, Mallart A, Bervar JF et al. Physiologic correlates of dyspnea in patients with morbid obesity. Int. J. Obes. 31, 700-706 (2006).
34. Ladosky W, Botelho MAM, Albuquerque JP. Chest mechanics in morbidly obese non-hypoventilated patients. Respir. Med. 95, 281-286 (2001).
35. Masa JF, Celli BR, Riesco JA, Sanchez de Cos J, Disdier C, Sojo A. Noninvasive positive pressure ventilation and not oxygen may prevent overt ventilatory failure in patients with chest wall diseases. Chest 112, 207-213 (1997).
36. Koenig SM. Pulmonary complications of obesity. Am. J. Med. Sci. 321, 249-279 (2001).
37. Weiner P, Waizman J, Weiner M, Rabner M, Magadle R, Zamir D. Infuence of excessive weight loss after gastroplasty for morbid obesity on respiratory muscle performance. Thorax 53, 39-42 (1998).
38. Farkas GA, Gosselin LE, Zhan WZ, Schlenker EH, Sieck GC. Histochemical and mechanical properties of diaphragm muscle in morbidly obese Zucker rats. J. Appl. Physiol. 77, 2250-2259 (1994).
39. Powers SK, Farkas GA, Demirel H et al. Effects of aging and obesity on respiratory muscle phenotype in Zucker rats. J. Appl. Physiol. 81, 1347-1354 (1996).
40. El-Gamal H, Khayat A, Shikora S, Unterborn JN. Relationship of dyspnea to respiratory drive and pulmonary function tests in obese patients before and after weight loss. Chest 128, 3870-3874 (2005).
41. Lin CC. Effect of nasal CPAP on ventilatory drive in normocapnic and hypercapnic patients with obstructive sleep apnoea syndrome. Eur. Respir. J. 7, 2005-2010 (1994).
42. Chouri-Pontarollo N, Borel JC, Tamisier R, Wuyam B, Levy P, Pepin JL. Impaired objective daytime vigilance in obesity-hypoventilation syndrome: impact of noninvasive ventilation. Chest 131, 148-155 (2007).
43. de Lucas-Ramos P, de Miguel-Díez J, Santacruz-Siminiani A, González-Moro JMR, B u end ía-García MJ, Izquierdo-Alonso JL. Benefts at 1 year of nocturnal intermittent positive pressure ventilation in patients with obesity-hypoventilation syndrome. Resp. Med. 98, 961-967 (2004).
44. Han F, Chen E, Wei H, He Q, Ding D, Strohl KP. Treatment effects on carbon dioxide retention in patients with obstructive sleep apnea-hypopnea syndrome. Chest 119, 1814-1819 (2001).
45. Sampson MG, Grassino K. Neuromechanical properties in obese patients during carbon dioxide rebreathing. Am. J. Med. 75, 81-90 (1983).
46. Redolf S, Corda L, La Piana G, Spandrio S, Prometti P, Tantucci C. Long-term non-invasive ventilation increases chemosensitivity and leptin in obesity-hypoventilation syndrome. Respir. Med. 101, 1191-1195 (2007).
47. De Miguel Diez J, De Lucas Ramos P, Perez Parra JJ, Buendia Garcia MJ, Cubillo Marcos JM, Gonzalez-Moro JM. [Analysis of withdrawal from noninvasive mechanical ventilation in patients with obesity-hypoventilation syndrome. Medium term results]. Arch. Bronconeumol. 39, 292-297 (2003).
48. Banerjee D, Yee BJ, Piper AJ, Zwillich CW, Grunstein RR. Obesity hypoventilation syndrome: hypoxemia during continuous positive airway pressure. Chest 131, 1678-1684 (2007).
49. Kaw R, Hernandez AV, Walker E, Aboussouan L, Mokhlesi B. Determinants of hypercapnia in obese patients with obstructive sleep apnea: a systematic review and metaanalysis of cohort studies. Chest 136, 787-796 (2009).
50. Berger KI, Goldring RM, Rapoport DM. Obesity hypoventilation syndrome. Semin. Respir. Crit. Care Med. 30, 253-261 (2009).
51. Berger KI, Ayappa I, Sorkin IB, Norman RG, Rapoport DM, Goldring RM. Postevent ventilation as a function of CO2 load during respiratory events in obstructive sleep apnea. J. Appl. Physiol. 93, 917-924 (2002).
52. Ayappa I, Berger KI, Norman RG, Oppenheimer BW, Rapoport DM, Goldring RM. Hypercapnia and ventilatory periodicity in obstructive sleep apnea syndrome. Am. J. Respir. Crit. Care Med. 166, 1112-1115 (2002).
53. Norman RG, Goldring RM, Clain JM et al. Transition from acute to chronic hypercapnia in patients with periodic breathing: predictions from a computer model. J. Appl. Physiol. 100, 1733-1741 (2006).
54. 2 during a single nights sleep in patients with obstructive sleep apnea. Intern. Med. 36, 454-460 (1997).
55. Becker HF, Piper AJ, Flynn WE et al Breathing during sleep in patients with nocturnal desaturation. Am. J. Respir. Crit Care Med. 159, 112-118 (1999).
56. Kawata N, Tatsumi K, Terada J et al. Daytime hypercapnia in obstructive sleep apnea syndrome. Chest 132, 1832-1838 (2007).
57. Lee S-D, Nakano H, Farkas GA. Adenosinergic modulation of ventilation in obese zucker rats. Obes. Res. 13, 545-555 (2005).
58. Yang AL, Lo MJ, Ting H, Chen JS, Huang CY, Lee SD. GABAa and GABAb receptors differentially modulate volume and frequency in ventilatory compensation in obese Zucker rats. J. Appl. Physiol. 102, 350-357 (2007).
59. Hlavac MC, Catcheside PG, McDonald R, Eckert DJ, Windler S, McEvoy RD. Hypoxia impairs the arousal response to external resistive loading and airway occlusion during sleep. Sleep 29, 624-631 (2006).
60. Friedman J. The function of leptin in nutrition, weight and physiology. Nutr. Rev. 60, S1-S14 (2002).
61. O'Donnell CP, Tankersley CG, Polotsky VP, Schwartz AR, Smith PL. Leptin, obesity, and respiratory function. Respir. Physiol. 119, 163-170 (2000).
62. O'Donnell CP, Schaub CD, Haines AS et al. Leptin prevents respiratory depression in obesity. Am. J. Respir. Crit. Care Med. 159, 1477-1484 (1999).
63. Caro JF, Sinha MK, Kolaczynski JW, Zhang PL, Considine RV. Leptin: the tale of an obesity gene. Diabetes 45, 1455-1462 (1996).
64. Phipps PR, Starritt E, Caterson I, Grunstein RR. Association of serum leptin with hypoventilation in human obesity. Thorax 57, 75-76 (2002).
65. Shimura R, Tatsumi K, Nakamura A et al. Fat accumulation, leptin, and hypercapnia in obstructive sleep apnea-hypopnea syndrome. Chest 127, 543-549 (2005). (Pubitemid 40229315)
66. Tatsumi K, Kasahara Y, Kurosu K, Tanabe N, Takiguchi Y, Kuriyama T. Sleep oxygen desaturation and circulating leptin in obstructive sleep apnea-hypopnea syndrome. Chest 127, 716-721 (2005). (Pubitemid 40775497)
67. Yee BJ, Cheung J, Phipps P, Banerjee D, Piper AJ, Grunstein RR. Treatment of obesity hypoventilation syndrome and serum leptin. Respiration 73, 209-212 (2006).
68. Makinodan K, Yoshikawa M, Fukuoka A et al. Effect of serum leptin levels on hypercapnic ventilatory response in obstructive sleep apnea. Respiration 75, 257-264 (2008).
69. Campo A, Fruhbeck G, Zulueta JJ et al. Hyperleptinemia, respiratory drive and hypercapnic response in obese patients. Eur. Respir. J. 30, 223-231 (2007).
70. Tankersley CG, O'Donnell C, Daood MJ et al. Leptin attenuates respiratory complications associated with the obese phenotype. J. Appl. Physiol. 85, 2261-2269 (1998).
71. Ip MS, Lam KS, Ho C, Tsang KW, Lam W. Serum leptin and vascular risk factors in obstructive sleep apnea. Chest 118, 580-586 (2000).
72. Polotsky VY, Li J, Punjabi NM et al. Intermittent hypoxia increases insulin resistance in genetically obese mice. J. Physiol. 552, 253-264 (2003).
73. Masa JF, Celli BR, Riesco JA, Hernandez M, Sanchez De Cos J, Disdier C. The obesity hypoventilation syndrome can be treated with noninvasive mechanical ventilation. Chest 119, 1102-1107 (2001).
74. Perez de Llano LA, Golpe R, Ortiz Piquer M et al. Short-term and long-term effects of nasal intermittent positive pressure ventilation in patients with obesity-hypoventilation syndrome. Chest 128, 587-594 (2005).
75. Hida W, Okabe S, Tatsumi K et al. Nasal continuous positive airway pressure improves quality of life in obesity hypoventilation syndrome. Sleep Breath. 7, 3-12 (2003).
76. Lin CC, Wu KM, Chou CS, Liaw SF. Oral airway resistance during wakefulness in eucapnic and hypercapnic sleep apnea syndrome. Respir. Physiol. Neurobiol. 139, 215-224 (2004).
77. Yamane T, Date T, Tokuda M et al. Hypoxemia in inferior pulmonary veins in supine position is dependent on obesity. Am. J. Respir. Crit. Care Med. 178, 295-299 (2008).
78. Zwillich C, Welsh CH. Hypercapnic obstructive sleep apnea: an underappreciated marker of severity. Chest 132, 1729-1730 (2007).
79. Akashiba T, Kawahara S, Kosaka N et al. Determinants of chronic hypercapnia in Japanese men with obstructive sleep apnea syndrome. Chest 121, 415-421 (2002).
80. Ong KC, Clerk AA. Comparison of the severity of sleep-disordered breathing in Asian and Caucasian patients seen at a sleep disorders center. Respir. Med. 92, 843-848 (1998).
81. Storre JH, Seuthe B, Fiechter R et al. Average volume-assured pressure support in obesity hypoventilation: a randomized crossover trial. Chest 130, 815-821 (2006).
82. Morgenthaler TI, Aurora N, Brown T et al. Practice parameters for the use of autotitrating continuous positive airway pressure devices for titrating pressures and treating adult patients with obstructive sleep apnea syndrome: an update for 2007. Sleep 31, 141-147 (2008).
83. Perez de Llano LA, Golpe R, Ortiz Piquer M et al. Clinical heterogeneity among patients with obesity hypoventilation syndrome: therapeutic implications. Respiration 75, 34-39 (2008).
84. Janssens JP, Derivaz S, Breitenstein E et al. Changing patterns in long-term noninvasive ventilation: a 7-year prospective study in the Geneva Lake area. Chest 123, 67-79 (2003).
85. Janssens JP, Metzger M, Sforza E. Impact of volume targeting on effcacy of bi-level non-invasive ventilation and sleep in obesity-hypoventilation. Respir. Med. 103, 165-172 (2009).
86. Diez JD, Ramos PD, Parra JJP, Garcia MJB, Marcos JMC, Gonzalez-Moro JMR. Analysis of withdrawal from noninvasive mechanical ventilation in patients with obesity-hypoventilation syndrome. Medium term results. Archivos De Bronconeumologia 39, 292-297 (2003).
87. Nickol AH, Hart N, Hopkinson NS, Moxham J, Simonds A, Polkey MI. Mechanisms of improvement of respiratory failure in patients with restrictive thoracic disease treated with non-invasive ventilation. Thorax 60, 754-760 (2005).
88. Guo YF, Sforza E, Janssens JP. Respiratory patterns during sleep in obesity-hypoventilation patients treated with nocturnal pressure support: a preliminary report. Chest 131, 1090-1099 (2007).
89. Fanfulla F, Taurino AE, Lupo ND, Trentin R, D'Ambrosio C, Nava S. Effect of sleep on patient/ventilator asynchrony in patients undergoing chronic non-invasive mechanical ventilation. Respir. Med. 101, 1702-1707 (2007).
90. Johnson KG, Johnson DC. Bilevel positive airway pressure worsens central apneas during sleep. Chest 128, 2141-2150 (2005).
91. Davila-Cervantes A, Dominguez-Cherit G, Borunda D et al. Impact of surgically-induced weight loss on respiratory function: a prospective analysis. Obes. Surg. 14, 1389-1392 (2004).
92. Buchwald H, Avidor Y, Braunwald E et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 292, 1724-1737 (2004).
93. Guardiano SA, Scott JA, Ware JC, Schechner SA. The long-term results of gastric bypass on indexes of sleep apnea. Chest 124, 1615-1619 (2003).
94. Christou NV, Look D, Maclean LD. Weight gain after short-and long-limb gastric bypass in patients followed for longer than 10 years. Ann. Surg. 244, 734-740 (2006).
95. Sjostrom L, Lindroos A-K, Peltonen M et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N. Engl. J. Med. 351, 2683-2693 (2004).
96. Marti-Valeri C, Sabate A, Masdevall C, Dalmau A. Improvement of associated respiratory problems in morbidly obese patients after open Roux-en-Y gastric bypass. Obes. Surg. 17, 1102-1110 (2007).
97. Greenburg DL, Lettieri CJ, Eliasson AH. Effects of surgical weight loss on measures of obstructive sleep apnea: a meta-analysis. Am. J. Med. 122, 535-542 (2009).
98. Lettieri CJ, Eliasson AH, Greenburg DL. Persistence of obstructive sleep apnea after surgical weight loss. J. Clin. Sleep Med. 4, 333-338 (2008).
99. Castano V, Valencia-Flores M, Orea A et al. Effect of bariatric surgery on obstructive sleep apnea and hypopnea syndrome, electrocardiogram, and pulmonary arterial pressure. Obes. Surg. 14, 755-762 (2004).
100. Pillar G, Peled R, Lavie P. Recurrence of sleep apnea without concomitant weight increase 7.5 years after weight reduction surgery. Chest 106, 1702-1704 (1994).
101. Sutton FD, Zwillich CW, Creagh CE, Pierson DJ, Weil JV. Progesterone for outpatient treatment of Pickwickian syndrome. Ann. Intern. Med. 83, 476-479 (1975).
102. Rapoport DM, Garay SM, Epstein H, Goldring RM. Hypercapnia in the obstructive sleep apnea syndrome. A reevaluation of the "Pickwickian syndrome". Chest 89, 627-635 (1986).
103. Tojima H, Kunitomo F, Kimura H, Tatsumi K, Kuriyama T, Honda Y. Effects of acetazolamide in patients with the sleep apnoea syndrome. Thorax 43, 113-119 (1988). (Pubitemid 18045557)
104. Cook WR, Benich JJ, Wooten SA. Indices of severity of obstructive sleep apnea syndrome do not change during medroxyprogesterone acetate therapy. Chest 96, 262-266 (1989).
105. Saaresranta T, Irjala K, Polo O. Effect of medroxyprogesterone on arterial blood gases, leptin and neuropeptide Y in postmenopausal females. Eur. Respir. J. 20, 1413-1418 (2002). (Pubitemid 35460608)